This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Medical University of Vienna. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Innovations of Johannes Kovarik in Pharmaceutical Composition
Introduction
Johannes Kovarik is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory conditions. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Kovarik's latest patents focus on the complement split product C4d for the treatment of various inflammatory conditions. The first patent describes a pharmaceutical composition that utilizes complement split product C4d to treat conditions such as graft rejection, graft versus host disease, autoimmune diseases, and atopy. The invention emphasizes the use of C4d multimers and their application in medicine. Additionally, it introduces a protein complex comprising C4d interacting with its ILT4 receptor, which may be utilized in screening methods. The patent also covers antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.
Career Highlights
Kovarik is affiliated with the Medical University of Vienna, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic options for patients suffering from inflammatory conditions.
Collaborations
Kovarik collaborates with esteemed colleagues such as Johannes Hofer and Peter Steinberger, contributing to a dynamic research environment that fosters innovation.
Conclusion
Johannes Kovarik's contributions to pharmaceutical compositions highlight his role as a key inventor in the medical field. His innovative approaches to treating inflammatory conditions have the potential to significantly enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
